Literature DB >> 33673131

mRNA Vaccines against Flaviviruses.

Clayton J Wollner1, Justin M Richner1.   

Abstract

Numerous vaccines have now been developed using the mRNA platform. In this approach, mRNA coding for a viral antigen is in vitro synthesized and injected into the host leading to exogenous protein expression and robust immune responses. Vaccines can be rapidly developed utilizing the mRNA platform in the face of emerging pandemics. Additionally, the mRNA coding region can be easily manipulated to test novel hypotheses in order to combat viral infections which have remained refractory to traditional vaccine approaches. Flaviviruses are a diverse family of viruses that cause widespread disease and have pandemic potential. In this review, we discuss the mRNA vaccines which have been developed against diverse flaviviruses.

Entities:  

Keywords:  Dengue; Zika; flavivirus; mRNA vaccines; tick-borne encephalitis

Year:  2021        PMID: 33673131     DOI: 10.3390/vaccines9020148

Source DB:  PubMed          Journal:  Vaccines (Basel)        ISSN: 2076-393X


  7 in total

1.  A multiple-target mRNA-LNP vaccine induces protective immunity against experimental multi-serotype DENV in mice.

Authors:  Lihong He; Wenqiang Sun; Limin Yang; Wenjun Liu; Jing Li
Journal:  Virol Sin       Date:  2022-07-12       Impact factor: 6.947

Review 2.  mRNA vaccines for infectious diseases: principles, delivery and clinical translation.

Authors:  Namit Chaudhary; Drew Weissman; Kathryn A Whitehead
Journal:  Nat Rev Drug Discov       Date:  2021-08-25       Impact factor: 112.288

Review 3.  From Recoding to Peptides for MHC Class I Immune Display: Enriching Viral Expression, Virus Vulnerability and Virus Evasion.

Authors:  John F Atkins; Kate M O'Connor; Pramod R Bhatt; Gary Loughran
Journal:  Viruses       Date:  2021-06-27       Impact factor: 5.048

Review 4.  Advances in mRNA and other vaccines against MERS-CoV.

Authors:  Wanbo Tai; Xiujuan Zhang; Yang Yang; Jiang Zhu; Lanying Du
Journal:  Transl Res       Date:  2021-11-19       Impact factor: 7.012

Review 5.  Current status and perspectives on vaccine development against dengue virus infection.

Authors:  Jisang Park; Ju Kim; Yong-Suk Jang
Journal:  J Microbiol       Date:  2022-02-14       Impact factor: 2.902

Review 6.  Potential of mRNA vaccines to become versatile cancer vaccines.

Authors:  Shiu-Ying Tsao
Journal:  World J Clin Oncol       Date:  2022-08-24

7.  mRNA Innovates the Vaccine Field.

Authors:  Norbert Pardi
Journal:  Vaccines (Basel)       Date:  2021-05-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.